AI heart scans could bring lifesaving diagnosis to remote australia

NCT ID NCT05558605

Recruiting now Diagnosis Sponsor: Baker Heart and Diabetes Institute Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether artificial intelligence can help guide heart ultrasounds in rural and remote Australia, where access to expert imaging is limited. Over 600 adults with heart risk factors or symptoms will receive either AI-guided or standard echocardiography. The goal is to see if AI can improve diagnosis of heart failure and valve disease, potentially making care more equitable.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: AI-guided echocardiography
What this could lead to: If successful, this could make heart imaging more accessible in rural areas, leading to earlier diagnosis and better management of heart failure and valve disease.
What could go wrong: This is a diagnostic trial, not a treatment. The AI tool may not perform as well as expert-led scans, and results may not apply to all populations or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

heart failure heart valve disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEART FAILURE VALVE HEART DISEASE

Contacts and locations

Locations

Alice Springs Hospital
RECRUITING

Alice Springs, Northern Territory, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.